Olfactory testing to assess risk in newborns with birth asphyxia
Official title: Olfactory Memory in Infants With Signs of Asphyxia: An Early Indicator of Neurodevelopmental Outcomes
Run by University of Parma · NCT06744244 · Data updated 2026-11-12
This study is testing if smelling different scents can help find newborns with mild to moderate birth asphyxia who might be at risk for serious brain problems.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 6 Hours to 72 Hours |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | University of Parma Academic / other |
| Locations | 1 site (Parma) |
| Status | Recruiting |
| Started | September 10, 2024 |
| Main results expected | January 2025 |
| Study ends | September 10, 2026 |
| Registry record updated | December 31, 2024 |
| Trial ID | NCT06744244 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are term newborns (37-41 weeks gestational age) with signs of mild to moderate asphyxia at birth.
✕Probably not a fit
Patients who are preterm, post-term, or have significant congenital anomalies or genetic syndromes may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study evaluates the olfactory function in term newborns who exhibit signs of mild to moderate birth asphyxia. By assessing olfactory memory through habituation to repeated odors, the study aims to identify newborns at high risk for hypoxic-ischemic encephalopathy, a severe neurological condition. The methodology includes olfactory testing alongside monitoring vital signs and neurodevelopmental assessments. Early identification of at-risk infants could facilitate timely interventions to improve their outcomes.
Why it matters
Potential benefit: If successful, this study could lead to improved early identification and intervention strategies for newborns at risk of neurodevelopmental disabilities due to birth asphyxia.
How similar studies have gone: While olfactory function has been studied in adults with neurological disorders, this approach in newborns with asphyxia is novel and has not been previously tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Term newborns (37-41 weeks of gestational age) with signs of asphyxia at birth (cord pH \< 7.10 and/or BE \> -12). * Maternal age \> 18 years. * No medication use during pregnancy (e.g., antipsychotics, antidepressants, sedatives, anticonvulsants, anxiolytics). * Absence of maternal infections. * Apgar score \< 5 at 10 minutes of life. * Newborns with mild asphyxia at birth. * Newborns with moderate asphyxia at birth, at risk of developing hypoxic-ischemic encephalopathy, who don't need hypothermia treatment. * Newborns with severe asphyxia at birth, at risk of developing hypoxic-ischemic encephalopathy who don't need hypothermia treatment. Exclusion Criteria: * Post-term infants (gestational age \> 42 weeks). * Preterm infants (gestational age \< 37 weeks). * Infants with genetic syndromes or congenital anomalies. * Infants from mothers using drugs of abuse. * Infants with scalp injuries or lesions. * Infants with microcephaly. * Infants who underwent therapeutic hypothermia.
Where it's running
-
Azienda Ospedaliero-Universitaria di Parma
Parma, Italy Recruiting
Study contacts
- Principal investigator: Serafina Perrone, MD, PhD — Università di Parma
- Study coordinator: Serafina Perrone, MD, PhD
- Email: serafina.perrone@unipr.it
- Phone: 3388704211
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Preserving the jawbone after a tooth extraction using hyaluronic acid and polynucleotides
This trial will test whether filling an extraction socket with a bovine bone graft plus a polynucleotide-rich hyaluronic acid gel helps preserve the jawbone and supports implant placement in adults needing a single tooth extraction.
-
Personalized plant-based diet to improve heart and metabolic health
This study is testing if a personalized plant-based diet high in certain compounds can improve heart and metabolic health in people at risk for these issues.
-
Exploring how the body processes plant compounds from coffee and other foods
This study is testing how healthy adults process plant compounds found in coffee and other foods to see how it affects their health.
-
Registry for Aortic Valve Replacement Treatments in Europe
This study is collecting data from patients in Europe to see how well different surgical treatments for severe aortic valve stenosis work and how they affect quality of life.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.